Liabilities, Current of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Intra-Cellular Therapies, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Liabilities, Current for the quarter ending 31 Dec 2024 was $205,704,000, a 67% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $205,704,000 +$82,159,000 +67% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $166,113,000 +$63,021,000 +61% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $161,775,000 +$69,695,000 +76% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $134,801,000 +$55,214,000 +69% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $123,545,000 +$40,309,000 +48% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $103,092,000 +$25,682,000 +33% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $92,080,000 +$21,446,000 +30% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $79,587,000 +$20,513,000 +35% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $83,236,000 +$29,879,000 +56% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $77,410,000 +$27,514,437 +55% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $70,634,000 +$20,212,063 +40% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $59,074,000 +$19,372,290 +49% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $53,357,000 +$16,503,777 +45% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $49,895,563 +$11,866,846 +31% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $50,421,937 +$10,179,222 +25% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $39,701,710 +$8,625,346 +28% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $36,853,223 +$629,204 +1.7% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $38,028,717 +$4,655,618 +14% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $40,242,715 +$7,716,228 +24% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $31,076,364 -$2,422,937 -7.2% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $36,224,019 -$75,166 -0.21% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $33,373,099 +$4,244,203 +15% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $32,526,487 +$13,591,120 +72% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $33,499,301 +$13,846,533 +70% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $36,299,185 +$22,089,579 +155% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $29,128,896 +$17,253,743 +145% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $18,935,367 +$11,972,648 +172% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $19,652,768 +$3,334,112 +20% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $14,209,606 +$3,677,272 +35% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $11,875,153 -$128,814,752 -92% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $6,962,719 -$12,418,349 -64% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $16,318,656 +$7,371,984 +82% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $10,532,334 +$4,268,822 +68% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $140,689,905 +$130,302,909 +1254% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $19,381,068 +$10,062,975 +108% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $8,946,672 -$5,646,069 -39% 31 Mar 2016 10-Q 28 Apr 2016 2016 Q1
Q4 2015 $6,263,512 -$4,293,552 -41% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $10,386,996 +$6,809,395 +190% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $9,318,093 +$6,578,839 +240% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $14,592,741 +$10,681,106 +273% 31 Mar 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 $10,557,064 +$3,723,027 +54% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $3,577,601 -$4,197,061 -54% 30 Sep 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 $2,739,254 -$30,292,746 -92% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $3,911,635 -$22,258,365 -85% 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $6,834,037 +$3,994,442 +141% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $7,774,662 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 $33,032,000 30 Jun 2013 10-Q 15 Aug 2013 2013 Q1
Q1 2013 $26,170,000 31 Mar 2013 10-Q 15 Aug 2013 2013 Q1
Q4 2012 $2,839,595 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.